Centessa Pharmaceuticals Presents Preclinical Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024)
September 26, 2024 06:00 ET
|
Centessa Pharmaceuticals plc
Late-breaking poster presentation of non-human primate (NHP) data support ORX142 as novel drug candidate for the treatment of excessive daytime sleepiness (EDS) in select neurological,...
Lulus Joins Forces With Dillard’s in Strategic U.S. Wholesale Expansion
September 26, 2024 06:00 ET
|
Lulu's Fashion Lounge Holdings, Inc.
CHICO, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Lulu's Fashion Lounge Holdings, Inc. (“Lulus” or the “Company”) (Nasdaq: LVLU), the attainable luxury brand for women, today announced a strategic...
GPTBots.ai Partners with QSTP Incubated Startup sKora Tech to Revolutionize AI Services in Sports
September 26, 2024 05:00 ET
|
Aurora Mobile Limited
DOHA, Qatar, Sept. 26, 2024 (GLOBE NEWSWIRE) -- GPTBots.ai, a leading global provider of AI bot services for business operations, is thrilled to announce a groundbreaking partnership with sKora...
Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024
September 26, 2024 02:30 ET
|
Abivax
Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024 Professor Bruce E. Sands, MD to present oral presentation of Phase 2b, open-label, maintenance efficacy and...
SEALCOIN AG Announces Final SEALCOIN Timeline, Whitepaper Release, and Tokenomics Details
September 26, 2024 01:00 ET
|
Wisekey International Holding Ltd.
SEALCOIN AG Announces Final SEALCOIN Timeline, Whitepaper Release, and Tokenomics Details Geneva, Switzerland – September 26, 2024: WISeKey International Holding Ltd. (“WISeKey” or the “Company”)...
Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib)
September 26, 2024 01:00 ET
|
Pharming Group N.V.
For media and investors only Indicated for adult and pediatric patients 12 years of age and older with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) Leiden, the...
MDxHealth Announces Pricing of Offering of Ordinary Shares
September 25, 2024 21:31 ET
|
mdxhealth
MDxHealth Announces Pricing of Offering of Ordinary Shares IRVINE, CA, and HERSTAL, BELGIUM – September 25, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (“mdxhealth” or the “Company“), a...
Wave Life Sciences Prices Upsized $200 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
September 25, 2024 21:14 ET
|
Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to...
Lincoln Tech Launches HVAC and Electrical Career Training at Moorestown, NJ Campus
September 25, 2024 20:26 ET
|
Lincoln Educational Services
Parsippany, NJ, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Lincoln Educational Services Corporation (NASDAQ: LINC), a national leader in specialized technical training for more than 75 years, has announced...
BioAge Labs Announces Pricing of Upsized Initial Public Offering
September 25, 2024 20:00 ET
|
BioAge Labs, Inc.
RICHMOND, Calif., Sept. 25, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (“BioAge”) (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic...